Tae Keun Cho

Title: Tae Keun Cho: Innovator in Pharmaceutical Composition

Introduction

Tae Keun Cho is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance medicinal effects while minimizing side effects.

Latest Patents

Tae Keun Cho holds a patent for a pharmaceutical composition comprising an antiplatelet agent and a gastric acid secretion inhibitor. The invention provides a composition that includes clopidogrel or its pharmaceutically acceptable salts, along with tegoprazan or its pharmaceutically acceptable salts as active ingredients. This innovative composition is designed to maintain the medicinal effect of clopidogrel while preventing or treating gastrointestinal disorders, a common side effect associated with its use. He has 1 patent to his name.

Career Highlights

Throughout his career, Tae Keun Cho has worked with prominent companies in the pharmaceutical industry, including Hk Inno.n Corporation and CJ Healthcare Corporation. His work has focused on improving patient outcomes through innovative drug formulations.

Collaborations

Tae Keun Cho has collaborated with talented individuals in his field, including Young Dae Cho and Eunji Kwon. These collaborations have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Tae Keun Cho is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly improve patient care. His innovative approach to combining antiplatelet agents with gastric acid secretion inhibitors showcases his commitment to addressing the challenges faced by patients using clopidogrel.